Subtype
Pancreatic Exocrine Neoplasm
CI-CAN-00003563Explore in graph →
Non-malignant371 active trials5 approved drugs27 evidence items
- NCIt
- C4445
Loading cancer entity…
Subtype
CI-CAN-00003563Explore in graph →
Clinical trials
976 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07612930 | Expanded Access to PCNAT-01 for Patients With Resected Pancreatic Ductal Adenocarcinoma Following Surgical Resection and Adjuvant Therapy | available | — | — | Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.INDUSTRY | 0 | May 29, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 29, 2026source: clinicaltrials